Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2).

Cocco E, Javier Carmona F, Razavi P, Won HH, Cai Y, Rossi V, Chan C, Cownie J, Soong J, Toska E, Shifman SG, Sarotto I, Savas P, Wick MJ, Papadopoulos KP, Moriarty A, Cutler RE Jr, Avogadri-Connors F, Lalani AS, Bryce RP, Chandarlapaty S, Hyman DM, Solit DB, Boni V, Loi S, Baselga J, Berger MF, Montemurro F, Scaltriti M.

Sci Signal. 2018 Oct 9;11(551). pii: eaat9773. doi: 10.1126/scisignal.aat9773.

PMID:
30301790
2.

Combined high-speed holographic shape and full-field displacement measurements of tympanic membrane.

Razavi P, Tang H, Rosowski JJ, Furlong C, Cheng JT.

J Biomed Opt. 2018 Sep;24(3):1-12. doi: 10.1117/1.JBO.24.3.031008.

PMID:
30255670
3.

The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers.

Razavi P, Chang MT, Xu G, Bandlamudi C, Ross DS, Vasan N, Cai Y, Bielski CM, Donoghue MTA, Jonsson P, Penson A, Shen R, Pareja F, Kundra R, Middha S, Cheng ML, Zehir A, Kandoth C, Patel R, Huberman K, Smyth LM, Jhaveri K, Modi S, Traina TA, Dang C, Zhang W, Weigelt B, Li BT, Ladanyi M, Hyman DM, Schultz N, Robson ME, Hudis C, Brogi E, Viale A, Norton L, Dickler MN, Berger MF, Iacobuzio-Donahue CA, Chandarlapaty S, Scaltriti M, Reis-Filho JS, Solit DB, Taylor BS, Baselga J.

Cancer Cell. 2018 Sep 10;34(3):427-438.e6. doi: 10.1016/j.ccell.2018.08.008.

PMID:
30205045
4.

Immunohistochemical analysis of estrogen receptor in breast cancer with ESR1 mutations detected by hybrid capture-based next-generation sequencing.

Ross DS, Zehir A, Brogi E, Konno F, Krystel-Whittemore M, Edelweiss M, Berger MF, Toy W, Chandarlapaty S, Razavi P, Baselga J, Wen HY.

Mod Pathol. 2018 Aug 29. doi: 10.1038/s41379-018-0116-5. [Epub ahead of print]

PMID:
30158597
5.

Genome doubling shapes the evolution and prognosis of advanced cancers.

Bielski CM, Zehir A, Penson AV, Donoghue MTA, Chatila W, Armenia J, Chang MT, Schram AM, Jonsson P, Bandlamudi C, Razavi P, Iyer G, Robson ME, Stadler ZK, Schultz N, Baselga J, Solit DB, Hyman DM, Berger MF, Taylor BS.

Nat Genet. 2018 Aug;50(8):1189-1195. doi: 10.1038/s41588-018-0165-1. Epub 2018 Jul 16.

PMID:
30013179
6.

KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function.

Gala K, Li Q, Sinha A, Razavi P, Dorso M, Sanchez-Vega F, Chung YR, Hendrickson R, Hsieh JJ, Berger M, Schultz N, Pastore A, Abdel-Wahab O, Chandarlapaty S.

Oncogene. 2018 Aug;37(34):4692-4710. doi: 10.1038/s41388-018-0273-5. Epub 2018 May 14.

7.

Accelerating Discovery of Functional Mutant Alleles in Cancer.

Chang MT, Bhattarai TS, Schram AM, Bielski CM, Donoghue MTA, Jonsson P, Chakravarty D, Phillips S, Kandoth C, Penson A, Gorelick A, Shamu T, Patel S, Harris C, Gao J, Sumer SO, Kundra R, Razavi P, Li BT, Reales DN, Socci ND, Jayakumaran G, Zehir A, Benayed R, Arcila ME, Chandarlapaty S, Ladanyi M, Schultz N, Baselga J, Berger MF, Rosen N, Solit DB, Hyman DM, Taylor BS.

Cancer Discov. 2018 Feb;8(2):174-183. doi: 10.1158/2159-8290.CD-17-0321. Epub 2017 Dec 15.

PMID:
29247016
8.

Effect of luting agent on the load to failure and accelerated-fatigue resistance of lithium disilicate laminate veneers.

Gresnigt MMM, Özcan M, Carvalho M, Lazari P, Cune MS, Razavi P, Magne P.

Dent Mater. 2017 Dec;33(12):1392-1401. doi: 10.1016/j.dental.2017.09.010. Epub 2017 Nov 1.

PMID:
29079354
9.

Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.

Zehir A, Benayed R, Shah RH, Syed A, Middha S, Kim HR, Srinivasan P, Gao J, Chakravarty D, Devlin SM, Hellmann MD, Barron DA, Schram AM, Hameed M, Dogan S, Ross DS, Hechtman JF, DeLair DF, Yao J, Mandelker DL, Cheng DT, Chandramohan R, Mohanty AS, Ptashkin RN, Jayakumaran G, Prasad M, Syed MH, Rema AB, Liu ZY, Nafa K, Borsu L, Sadowska J, Casanova J, Bacares R, Kiecka IJ, Razumova A, Son JB, Stewart L, Baldi T, Mullaney KA, Al-Ahmadie H, Vakiani E, Abeshouse AA, Penson AV, Jonsson P, Camacho N, Chang MT, Won HH, Gross BE, Kundra R, Heins ZJ, Chen HW, Phillips S, Zhang H, Wang J, Ochoa A, Wills J, Eubank M, Thomas SB, Gardos SM, Reales DN, Galle J, Durany R, Cambria R, Abida W, Cercek A, Feldman DR, Gounder MM, Hakimi AA, Harding JJ, Iyer G, Janjigian YY, Jordan EJ, Kelly CM, Lowery MA, Morris LGT, Omuro AM, Raj N, Razavi P, Shoushtari AN, Shukla N, Soumerai TE, Varghese AM, Yaeger R, Coleman J, Bochner B, Riely GJ, Saltz LB, Scher HI, Sabbatini PJ, Robson ME, Klimstra DS, Taylor BS, Baselga J, Schultz N, Hyman DM, Arcila ME, Solit DB, Ladanyi M, Berger MF.

Nat Med. 2017 Aug 4;23(8):1004. doi: 10.1038/nm0817-1004c. No abstract available.

PMID:
28777785
10.

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.

Zehir A, Benayed R, Shah RH, Syed A, Middha S, Kim HR, Srinivasan P, Gao J, Chakravarty D, Devlin SM, Hellmann MD, Barron DA, Schram AM, Hameed M, Dogan S, Ross DS, Hechtman JF, DeLair DF, Yao J, Mandelker DL, Cheng DT, Chandramohan R, Mohanty AS, Ptashkin RN, Jayakumaran G, Prasad M, Syed MH, Rema AB, Liu ZY, Nafa K, Borsu L, Sadowska J, Casanova J, Bacares R, Kiecka IJ, Razumova A, Son JB, Stewart L, Baldi T, Mullaney KA, Al-Ahmadie H, Vakiani E, Abeshouse AA, Penson AV, Jonsson P, Camacho N, Chang MT, Won HH, Gross BE, Kundra R, Heins ZJ, Chen HW, Phillips S, Zhang H, Wang J, Ochoa A, Wills J, Eubank M, Thomas SB, Gardos SM, Reales DN, Galle J, Durany R, Cambria R, Abida W, Cercek A, Feldman DR, Gounder MM, Hakimi AA, Harding JJ, Iyer G, Janjigian YY, Jordan EJ, Kelly CM, Lowery MA, Morris LGT, Omuro AM, Raj N, Razavi P, Shoushtari AN, Shukla N, Soumerai TE, Varghese AM, Yaeger R, Coleman J, Bochner B, Riely GJ, Saltz LB, Scher HI, Sabbatini PJ, Robson ME, Klimstra DS, Taylor BS, Baselga J, Schultz N, Hyman DM, Arcila ME, Solit DB, Ladanyi M, Berger MF.

Nat Med. 2017 Jun;23(6):703-713. doi: 10.1038/nm.4333. Epub 2017 May 8. Erratum in: Nat Med. 2017 Aug 4;23 (8):1004.

11.

Are Athletes' Doping-Related Attitudes Predicted by Their Perceptions of Coaches' Confrontation Efficacy?

Sullivan P, Razavi P.

Subst Use Misuse. 2017 Jul 3;52(8):1098-1103. doi: 10.1080/10826084.2016.1272613. Epub 2017 Apr 21.

PMID:
28429996
12.

Capturing Genomic Evolution of Lung Cancers through Liquid Biopsy for Circulating Tumor DNA.

Offin M, Chabon JJ, Razavi P, Isbell JM, Rudin CM, Diehn M, Li BT.

J Oncol. 2017;2017:4517834. doi: 10.1155/2017/4517834. Epub 2017 Mar 14. Review.

13.

A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel.

Smyth LM, Monson KR, Jhaveri K, Drilon A, Li BT, Abida W, Iyer G, Gerecitano JF, Gounder M, Harding JJ, Voss MH, Makker V, Ho AL, Razavi P, Iasonos A, Bialer P, Lacouture ME, Teitcher JB, Erinjeri JP, Katabi N, Fury MG, Hyman DM.

Invest New Drugs. 2017 Dec;35(6):742-750. doi: 10.1007/s10637-017-0445-0. Epub 2017 Mar 9.

PMID:
28281183
14.

Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status: Clinical Validation in the Context of a Hybrid Capture-Based, Comprehensive Solid Tumor Genomic Profiling Assay.

Ross DS, Zehir A, Cheng DT, Benayed R, Nafa K, Hechtman JF, Janjigian YY, Weigelt B, Razavi P, Hyman DM, Baselga J, Berger MF, Ladanyi M, Arcila ME.

J Mol Diagn. 2017 Mar;19(2):244-254. doi: 10.1016/j.jmoldx.2016.09.010. Epub 2016 Dec 25. Erratum in: J Mol Diagn. 2017 May;19(3):485.

15.

Activating ESR1 Mutations Differentially Affect the Efficacy of ER Antagonists.

Toy W, Weir H, Razavi P, Lawson M, Goeppert AU, Mazzola AM, Smith A, Wilson J, Morrow C, Wong WL, De Stanchina E, Carlson KE, Martin TS, Uddin S, Li Z, Fanning S, Katzenellenbogen JA, Greene G, Baselga J, Chandarlapaty S.

Cancer Discov. 2017 Mar;7(3):277-287. doi: 10.1158/2159-8290.CD-15-1523. Epub 2016 Dec 16.

16.

Cross-cultural similarities and differences in the experience of awe.

Razavi P, Zhang JW, Hekiert D, Yoo SH, Howell RT.

Emotion. 2016 Dec;16(8):1097-1101. Epub 2016 Sep 15.

PMID:
27632153
17.

Systematic Functional Characterization of Resistance to PI3K Inhibition in Breast Cancer.

Le X, Antony R, Razavi P, Treacy DJ, Luo F, Ghandi M, Castel P, Scaltriti M, Baselga J, Garraway LA.

Cancer Discov. 2016 Oct;6(10):1134-1147. doi: 10.1158/2159-8290.CD-16-0305. Epub 2016 Sep 7.

18.

PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kα Inhibition.

Castel P, Ellis H, Bago R, Toska E, Razavi P, Carmona FJ, Kannan S, Verma CS, Dickler M, Chandarlapaty S, Brogi E, Alessi DR, Baselga J, Scaltriti M.

Cancer Cell. 2016 Aug 8;30(2):229-242. doi: 10.1016/j.ccell.2016.06.004. Epub 2016 Jul 21.

19.

Response of the human tympanic membrane to transient acoustic and mechanical stimuli: Preliminary results.

Razavi P, Ravicz ME, Dobrev I, Cheng JT, Furlong C, Rosowski JJ.

Hear Res. 2016 Oct;340:15-24. doi: 10.1016/j.heares.2016.01.019. Epub 2016 Feb 12.

20.

Variable risk of second primary malignancy in multiple myeloma patients of different ethnic subgroups.

Ailawadhi S, Swaika A, Razavi P, Yang D, Chanan-Khan A.

Blood Cancer J. 2014 Sep 5;4:e243. doi: 10.1038/bcj.2014.63.

21.

Trends in childhood brain tumor incidence, 1973-2009.

McKean-Cowdin R, Razavi P, Barrington-Trimis J, Baldwin RT, Asgharzadeh S, Cockburn M, Tihan T, Preston-Martin S.

J Neurooncol. 2013 Nov;115(2):153-60. doi: 10.1007/s11060-013-1212-5. Epub 2013 Aug 8.

22.

Patterns of second primary malignancy risk in multiple myeloma patients before and after the introduction of novel therapeutics.

Razavi P, Rand KA, Cozen W, Chanan-Khan A, Usmani S, Ailawadhi S.

Blood Cancer J. 2013 Jun 28;3:e121. doi: 10.1038/bcj.2013.19.

23.

Endogenous sex steroids in premenopausal women and risk of breast cancer: the ORDET cohort.

Schernhammer ES, Sperati F, Razavi P, Agnoli C, Sieri S, Berrino F, Krogh V, Abbagnato C, Grioni S, Blandino G, Schunemann HJ, Muti P.

Breast Cancer Res. 2013 Jun 18;15(3):R46. doi: 10.1186/bcr3438.

24.

Alcohol and breast cancer risk among Asian-American women in Los Angeles County.

Wu AH, Vigen C, Razavi P, Tseng CC, Stancyzk FZ.

Breast Cancer Res. 2012 Nov 27;14(6):R151. doi: 10.1186/bcr3363.

25.

Eculizumab therapy results in rapid and sustained decreases in markers of thrombin generation and inflammation in patients with PNH independent of its effects on hemolysis and microparticle formation.

Weitz IC, Razavi P, Rochanda L, Zwicker J, Furie B, Manly D, Mackman N, Green R, Liebman HA.

Thromb Res. 2012 Sep;130(3):361-8. doi: 10.1016/j.thromres.2012.04.001. Epub 2012 Apr 28.

PMID:
22542362
26.

Outcome disparities in multiple myeloma: a SEER-based comparative analysis of ethnic subgroups.

Ailawadhi S, Aldoss IT, Yang D, Razavi P, Cozen W, Sher T, Chanan-Khan A.

Br J Haematol. 2012 Jul;158(1):91-8. doi: 10.1111/j.1365-2141.2012.09124.x. Epub 2012 Apr 26.

PMID:
22533740
27.

Quality of Life among Persons with HIV/AIDS in Iran: Internal Reliability and Validity of an International Instrument and Associated Factors.

Razavi P, Hajifathalian K, Saeidi B, Esmaeeli Djavid G, Rasoulinejad M, Hajiabdolbaghi M, Paydary K, Kheirandish P, Foroughi M, Seyedalinaghi S, Mohraz M, McFarland W.

AIDS Res Treat. 2012;2012:849406. doi: 10.1155/2012/849406. Epub 2012 Jan 12.

28.

Symptoms adversely impact survival among patients with cancer and unsuspected pulmonary embolism.

O'Connell CL, Razavi PA, Liebman HA.

J Clin Oncol. 2011 Nov 1;29(31):4208-9; author reply 4209-10. doi: 10.1200/JCO.2011.37.2730. Epub 2011 Oct 3. No abstract available.

PMID:
21969510
29.

Variations in sex hormone metabolism genes, postmenopausal hormone therapy and risk of endometrial cancer.

Razavi P, Lee E, Bernstein L, Van Den Berg D, Horn-Ross PL, Ursin G.

Int J Cancer. 2012 Apr 1;130(7):1629-38. doi: 10.1002/ijc.26163. Epub 2011 Aug 17.

30.

Rotating night shifts and risk of skin cancer in the nurses' health study.

Schernhammer ES, Razavi P, Li TY, Qureshi AA, Han J.

J Natl Cancer Inst. 2011 Apr 6;103(7):602-6. doi: 10.1093/jnci/djr044. Epub 2011 Feb 18.

31.

Unsuspected pulmonary emboli adversely impact survival in patients with cancer undergoing routine staging multi-row detector computed tomography scanning.

O'Connell C, Razavi P, Ghalichi M, Boyle S, Vasan S, Mark L, Caton A, Duddalwar V, Boswell W, Grabow K, Liebman HA.

J Thromb Haemost. 2011 Feb;9(2):305-11. doi: 10.1111/j.1538-7836.2010.04114.x.

32.

Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach.

Lee E, Hsu C, Haiman CA, Razavi P, Horn-Ross PL, Van Den Berg D, Bernstein L, Le Marchand L, Henderson BE, Setiawan VW, Ursin G.

Carcinogenesis. 2010 Aug;31(8):1392-9. doi: 10.1093/carcin/bgq113. Epub 2010 Jun 13.

33.

Nanowire transistors without junctions.

Colinge JP, Lee CW, Afzalian A, Akhavan ND, Yan R, Ferain I, Razavi P, O'Neill B, Blake A, White M, Kelleher AM, McCarthy B, Murphy R.

Nat Nanotechnol. 2010 Mar;5(3):225-9. doi: 10.1038/nnano.2010.15. Epub 2010 Feb 21.

PMID:
20173755
34.

Long-term postmenopausal hormone therapy and endometrial cancer.

Razavi P, Pike MC, Horn-Ross PL, Templeman C, Bernstein L, Ursin G.

Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):475-83. doi: 10.1158/1055-9965.EPI-09-0712. Epub 2010 Jan 19.

35.

Associations between polymorphisms in DNA repair genes and glioblastoma.

McKean-Cowdin R, Barnholtz-Sloan J, Inskip PD, Ruder AM, Butler M, Rajaraman P, Razavi P, Patoka J, Wiencke JK, Bondy ML, Wrensch M.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1118-26. doi: 10.1158/1055-9965.EPI-08-1078. Epub 2009 Mar 24.

36.

Virtual endoscopy: a promising new technology.

Wood BJ, Razavi P.

Am Fam Physician. 2002 Jul 1;66(1):107-12. Review.

37.

Esophageal exfoliative cytology samplers. A comparison of three types.

Sepehr A, Razavi P, Saidi F, Salehian P, Rahmani M, Shamshiri A.

Acta Cytol. 2000 Sep-Oct;44(5):797-804.

PMID:
11015982
38.

Identification of arylamine N-acetyltransferase activity in the bovine lens.

Gaudet SJ, Razavi P, Caiafa GJ, Chader GJ.

Curr Eye Res. 1995 Oct;14(10):873-7.

PMID:
8549152

Supplemental Content

Loading ...
Support Center